Our study further proved that instead of solely killing the tumors, the primary aim of Rh2 was to promote the oxidative phosphorylation function of tumors, change the behavior of tumor metabolism, promote tumors to shift to benign metabolic profile, and converge towards favorable biological behavior, ultimately leading to the activation of normal apoptotic programs. The gene discussed is RHAG; the disease is neoplasm.